Effect of CYP2C9 and SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of nateglinide in healthy Chinese male volunteers. [electronic resource]
Producer: 20130801Description: 407-13 p. digitalISSN:- 1432-1041
- Administration, Oral
- Area Under Curve
- Aryl Hydrocarbon Hydroxylases -- genetics
- Asian People -- genetics
- Biomarkers -- blood
- Blood Glucose -- drug effects
- China -- epidemiology
- Cyclohexanes -- administration & dosage
- Cytochrome P-450 CYP2C9
- Genotype
- Half-Life
- Humans
- Hypoglycemic Agents -- administration & dosage
- Liver-Specific Organic Anion Transporter 1
- Male
- Metabolic Clearance Rate
- Nateglinide
- Organic Anion Transporters -- genetics
- Pharmacogenetics
- Phenotype
- Phenylalanine -- administration & dosage
- Polymorphism, Single Nucleotide
- Prospective Studies
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.